{"id":12167,"date":"2026-10-23T12:41:40","date_gmt":"2026-10-23T16:41:40","guid":{"rendered":"https:\/\/crassulapharma.com\/?page_id=12167"},"modified":"2026-10-23T13:16:20","modified_gmt":"2026-10-23T17:16:20","slug":"q-niflex","status":"publish","type":"page","link":"https:\/\/crassulapharma.com\/es\/q-niflex\/","title":{"rendered":"Q-Niflex"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"12167\" class=\"elementor elementor-12167\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-fb53a37 e-con-full e-flex e-con e-parent\" data-id=\"fb53a37\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-cfb7093 elementor-widget elementor-widget-html\" data-id=\"cfb7093\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<!doctype html>\n<html lang=\"en\">\n<head>\n<meta charset=\"utf-8\">\n<meta name=\"viewport\" content=\"width=device-width, initial-scale=1\">\n<title>Q-Niflex (QuanticSphere\u2122 PQNS) \u2013 Crassula<\/title>\n<meta name=\"description\" content=\"Q-Niflex is a clinically engineered multi-pathway joint support formulation powered by QuanticSphere\u2122 PQNS: 16 synergistic actives, ~85\u201390% uptake.\">\n<link rel=\"preload\" href=\"fonts\/poppins-latin-600-normal.woff2\" as=\"font\" type=\"font\/woff2\" crossorigin>\n<link rel=\"preload\" href=\"fonts\/ibm-plex-sans-latin-400-normal.woff2\" as=\"font\" type=\"font\/woff2\" crossorigin>\n<style>\n@font-face{font-family:\"Poppins\";font-weight:500;font-style:normal;font-display:swap;src:url(fonts\/poppins-latin-500-normal.woff2) format(\"woff2\")}\n@font-face{font-family:\"Poppins\";font-weight:600;font-style:normal;font-display:swap;src:url(fonts\/poppins-latin-600-normal.woff2) format(\"woff2\")}\n@font-face{font-family:\"IBM Plex Sans\";font-weight:400;font-style:normal;font-display:swap;src:url(fonts\/ibm-plex-sans-latin-400-normal.woff2) format(\"woff2\")}\n@font-face{font-family:\"IBM Plex Sans\";font-weight:500;font-style:normal;font-display:swap;src:url(fonts\/ibm-plex-sans-latin-500-normal.woff2) format(\"woff2\")}\n\n:root{\n  --teal-deep:#4a0307; --teal-head:#7d0108; --teal:#a1020b; --teal-2:#b8101a; --teal-3:#7d0108;\n  --red:#f39200; --accent-text:#7d0108; --green:#f39200;\n  --action-teal:#a1020b; --ink:#2e0507; --ink-muted:#6a4a4d; --surface:#fbf3f3; --note:#fbf3f3;\n  --line:#f1dede;\n  --ease-out:cubic-bezier(.23,1,.32,1);\n  --font-head:\"Poppins\",system-ui,sans-serif;\n  --font-body:\"IBM Plex Sans\",system-ui,sans-serif;\n  --cx-gutter:clamp(20px,5vw,48px);\n  --cx-max:1120px;\n}\n*{box-sizing:border-box;margin:0}\nhtml{scroll-behavior:smooth;scroll-padding-top:24px;-webkit-text-size-adjust:100%}\nbody{font-family:var(--font-body);font-size:17px;line-height:1.6;color:var(--ink);background:#fff;-webkit-font-smoothing:antialiased;text-rendering:optimizeLegibility}\nimg{max-width:100%;height:auto;display:block}\na{color:var(--action-teal)}\n:focus-visible{outline:2px solid var(--action-teal);outline-offset:2px;border-radius:6px}\n.skip{position:absolute;left:12px;top:-60px;background:var(--ink);color:#fff;padding:10px 16px;border-radius:999px;z-index:100;text-decoration:none;font-family:var(--font-head);font-weight:500}\n.skip:focus{top:12px}\n.cx-wrap{width:100%;max-width:var(--cx-max);margin-inline:auto;padding-inline:var(--cx-gutter)}\n\n\/* Buttons *\/\n.btn{white-space:nowrap;display:inline-flex;align-items:center;justify-content:center;gap:8px;min-height:48px;padding:16px 28px;border-radius:6px;font:500 16px\/1 var(--font-head);text-decoration:none;cursor:pointer;border:1.5px solid transparent;\n  transition:background-color 150ms var(--ease-out),transform 150ms var(--ease-out),box-shadow 150ms var(--ease-out),color 150ms var(--ease-out)}\n.btn:active{transform:scale(.97)}\n.btn-primary{background:#fff;color:var(--teal-deep)}\n.btn-secondary{background:transparent;border-color:rgba(255,255,255,.85);color:#fff}\n.btn-sm{padding:12px 22px;min-height:48px;font-size:15px}\n@media (hover:hover) and (pointer:fine){\n  .btn-primary:hover{background:#fdf0dc;transform:translateY(-2px)}\n  .btn-secondary:hover{background:#fff;color:var(--teal-deep);transform:translateY(-2px)}\n}\n\n\/* Hero *\/\n.hero{position:relative;background:linear-gradient(125deg,#4a0307 0%,#7d0108 50%,#a1020b 100%);overflow:hidden;isolation:isolate;color:#fff}\n.hero::before{content:\"\";position:absolute;inset:0;z-index:-1;background:repeating-linear-gradient(115deg,rgba(255,255,255,.045) 0 1px,transparent 1px 46px)}\n.hero canvas{position:absolute;inset:0;width:100%;height:100%;z-index:-1;pointer-events:none}\n.hero::after{content:\"\";position:absolute;left:-6%;right:-6%;bottom:-1px;height:clamp(36px,6vw,70px);background:#fff;border-radius:50% 50% 0 0\/100% 100% 0 0}\n.hero .cx-wrap{display:grid;grid-template-columns:1fr 1fr;align-items:center;gap:clamp(24px,4vw,48px);padding-block:clamp(50px,8vw,50px) clamp(96px,11vw,132px)}\n.tag{display:inline-block;font:500 12px\/1 var(--font-body);letter-spacing:.12em;text-transform:uppercase;color:#fff;border:1px solid rgba(255,255,255,.4);border-radius:6px;padding:11px 16px;background:rgba(255,255,255,.08);margin-bottom:28px}\nh1{font:600 clamp(40px,7vw,64px)\/1.08 var(--font-head);letter-spacing:-.02em;color:#fff}\nh1 sup{font-size:.34em;vertical-align:top;position:relative;top:.55em;margin-left:.08em;letter-spacing:0}\n.generic{font:500 clamp(22px,3vw,28px)\/1.3 var(--font-head);color:rgba(255,255,255,.88);margin-top:10px}\n.strengths{display:flex;gap:10px;margin-top:26px;flex-wrap:wrap}\n.chip{font:600 20px\/1 var(--font-head);padding:12px 20px;border-radius:12px;color:#fff;font-variant-numeric:tabular-nums}\n.chip.t{background:#fff;color:var(--teal-head)}.chip.g{background:var(--red)}\n.cta-row{display:flex;gap:12px;flex-wrap:wrap;margin-top:36px}\n.hero-art{position:relative;width:100%;display:grid;place-items:center}\n.hero-art img{width:100%;max-width:460px;height:auto}\n@media (max-width:860px){.hero .cx-wrap{grid-template-columns:1fr}.hero-art{max-width:600px;width:100%;margin:0 auto}}\n\n\/* Spec strip *\/\n.specs{margin-top:-70px;position:relative;z-index:2}\n.specs ul{list-style:none;padding:0;display:grid;grid-template-columns:repeat(4,1fr);background:#fff;border:1px solid var(--line);border-radius:20px;box-shadow:0 14px 34px -18px rgba(74,3,7,.30)}\n.specs ul{overflow:hidden}\n.specs li{position:relative;transition:background-color 250ms var(--ease-out),transform 250ms var(--ease-out);display:flex;align-items:center;gap:14px;padding:22px 24px;border-left:1px solid var(--line)}\n.specs li:first-child{border-left:0}\n.specs li::after{content:\"\";position:absolute;left:0;right:0;bottom:0;height:3px;background:linear-gradient(90deg,var(--teal-2),var(--green));transform:scaleX(0);transform-origin:left;transition:transform 350ms var(--ease-out)}\n.specs .ico{transition:transform 300ms var(--ease-out),background-color 250ms var(--ease-out),box-shadow 300ms var(--ease-out)}\n.specs dd{transition:transform 300ms var(--ease-out),color 250ms var(--ease-out)}\n@media (hover:hover){\n  .specs li:hover{background:var(--note)}\n  .specs li:hover::after{transform:scaleX(1)}\n  .specs li:hover .ico{transform:translateY(-3px) scale(1.12) rotate(-6deg);background:var(--teal-deep);box-shadow:0 10px 18px -8px rgba(74,3,7,.55)}\n  .specs li:hover dd{color:var(--teal);transform:translateX(3px)}\n}\n.ico{flex:none;width:42px;height:42px;border-radius:50%;background:var(--action-teal);display:grid;place-items:center;color:#fff}\n.ico svg{width:20px;height:20px;stroke:currentColor;fill:none;stroke-width:1.8;stroke-linecap:round;stroke-linejoin:round}\n.specs dt{font:500 11px\/1.2 var(--font-body);letter-spacing:.12em;text-transform:uppercase;color:var(--ink-muted)}\n.specs dd{font:600 15.5px\/1.3 var(--font-head);margin-top:4px;color:var(--ink)}\n@media (max-width:900px){.specs ul{grid-template-columns:1fr 1fr}.specs li:nth-child(3){border-left:0}.specs li:nth-child(n+3){border-top:1px solid var(--line)}}\n@media (max-width:480px){.specs ul{grid-template-columns:1fr}.specs li{border-left:0!important}.specs li+li{border-top:1px solid var(--line)}}\n\n\/* Sections *\/\nsection{padding-block:clamp(56px,8vw,96px)}\n.h2{color:var(--teal-head);display:flex;align-items:center;gap:14px;font:600 clamp(28px,4vw,36px)\/1.15 var(--font-head);letter-spacing:-.01em;margin-bottom:28px}\n.h2::before{content:\"\";flex:none;width:6px;align-self:stretch;min-height:1.1em;border-radius:4px;background:linear-gradient(var(--teal-2),var(--green))}\n.prose p{max-width:68ch;color:var(--ink)}\n.prose p+p{margin-top:14px}\n.prose strong{font-weight:500;color:var(--action-teal);font-family:var(--font-head)}\n.about{padding-top:clamp(64px,9vw,104px)}\n\n\/* Indications *\/\n.indications{background:#fff;padding-top:0}\n.cards{display:grid;grid-template-columns:repeat(2,1fr);gap:20px}\n.card{background:var(--surface);border:1px solid var(--line);border-radius:20px;padding:28px;transition:transform 250ms var(--ease-out),box-shadow 250ms var(--ease-out),border-color 250ms var(--ease-out)}\n.card{position:relative;overflow:hidden}\n.card::after{content:\"\";position:absolute;left:0;right:0;bottom:0;height:4px;background:linear-gradient(90deg,var(--teal-2),var(--green));transform:scaleX(0);transform-origin:left;transition:transform 400ms var(--ease-out)}\n.card .ico{transition:transform 300ms var(--ease-out),background-color 250ms var(--ease-out),color 250ms var(--ease-out)}\n@media (hover:hover){\n  .card:hover{transform:translateY(-8px);box-shadow:0 24px 40px -22px rgba(74,3,7,.45);border-color:#e6b9bc;background:#fff}\n  .card:hover::after{transform:scaleX(1)}\n  .card:hover .ico{background:var(--teal);color:#fff;transform:rotate(-8deg) scale(1.12)}\n}\n.card .ico{width:38px;height:38px;background:#fff;color:var(--action-teal);border:1px solid var(--line);border-radius:12px;margin-bottom:18px}\n.card h3{color:var(--teal-head);font:600 19px\/1.3 var(--font-head);color:var(--ink);margin-bottom:10px}\n.card p{color:var(--ink-muted);font-size:16.5px}\n.card em{font-style:italic}\n@media (max-width:760px){.cards{grid-template-columns:1fr}}\n\n\/* Presentations *\/\n.presentations{background:var(--surface)}\n.pres{display:grid;grid-template-columns:1fr 1fr;gap:20px}\n.pcard{display:flex;align-items:center;gap:24px;background:#fff;border:1px solid var(--line);border-radius:20px;padding:26px 28px;position:relative;overflow:hidden;transition:transform 250ms var(--ease-out),box-shadow 250ms var(--ease-out)}\n.pcard::before{content:\"\";position:absolute;left:0;top:0;bottom:0;width:6px;background:var(--c)}\n.pcard::before{transition:width 300ms var(--ease-out)}\n.dose{transition:transform 350ms var(--ease-out)}\n@media (hover:hover){\n  .pcard:hover{transform:translateY(-6px);box-shadow:0 24px 40px -22px rgba(74,3,7,.45)}\n  .pcard:hover::before{width:14px}\n  .pcard:hover .dose{transform:scale(1.08) translateX(4px)}\n}\n.dose{font:600 clamp(40px,6vw,52px)\/1 var(--font-head);color:var(--c);letter-spacing:-.02em;white-space:nowrap}\n.dose small{font:500 18px\/1 var(--font-head);letter-spacing:0;margin-left:4px}\n.pcard h3{color:var(--teal-head);font:600 17px\/1.35 var(--font-head);margin-bottom:6px}\n.pcard p{color:var(--ink-muted);font-size:16px;line-height:1.5}\n@media (max-width:760px){.pres{grid-template-columns:1fr}}\n\n\/* Mechanism *\/\n.mech-intro{max-width:78ch;margin-bottom:44px}\n.mech-intro strong{font-weight:500;color:var(--action-teal);font-family:var(--font-head)}\n.mech-grid{display:grid;grid-template-columns:1.1fr .9fr;gap:clamp(28px,5vw,64px);align-items:start}\n.steps{list-style:none;padding:0;position:relative}\n.steps::before{content:\"\";position:absolute;left:19px;top:20px;bottom:30px;width:2px;background:linear-gradient(var(--action-teal),rgba(161,2,11,.08));transform-origin:top;transform:scaleY(var(--line,0));transition:transform 900ms var(--ease-out)}\n.steps li{position:relative;padding-left:64px;padding-bottom:34px;transition:transform 300ms var(--ease-out)}\n.num{transition:transform 300ms var(--ease-out),background-color 250ms var(--ease-out)}\n.steps h3{transition:color 250ms var(--ease-out)}\n@media (hover:hover){.steps li:hover{transform:translateX(6px)}.steps li:hover .num{transform:scale(1.18);background:var(--teal-deep)}.steps li:hover h3{color:var(--teal)}}\n.steps li:last-child{padding-bottom:0}\n.num{position:absolute;left:0;top:0;width:40px;height:40px;border-radius:50%;background:var(--action-teal);color:#fff;display:grid;place-items:center;font:600 16px\/1 var(--font-head);box-shadow:0 0 0 5px #fff}\n.steps h3{color:var(--teal-head);font:600 19px\/1.3 var(--font-head);color:var(--ink);margin:6px 0 6px}\n.steps p{color:var(--ink-muted)}\n@media (max-width:900px){.mech-grid{grid-template-columns:1fr}}\n\n\/* Flow diagram *\/\n.flow{background:var(--surface);border:1px solid var(--line);border-radius:24px;padding:28px clamp(18px,3vw,32px) 32px;text-align:center}\n.flow-title{font:600 12px\/1 var(--font-body);letter-spacing:.14em;text-transform:uppercase;color:var(--ink-muted);margin-bottom:22px}\n.node{display:block;margin-inline:auto;background:#fff;border:1.5px solid #ecd0d2;border-radius:12px;padding:10px 16px;max-width:300px;font:600 14px\/1.3 var(--font-head);color:var(--ink);opacity:0;transition:border-color 250ms var(--ease-out),box-shadow 250ms var(--ease-out),transform 250ms var(--ease-out)}\n.node small{display:block;font:400 12px\/1.3 var(--font-body);color:var(--ink-muted);margin-top:2px}\n.node.primary{background:var(--action-teal);border-color:var(--action-teal);color:#fff;border-radius:999px;padding:14px 20px;font-size:16px}\n.node.primary small{color:#fff;font-size:12.5px}\n.node.end{background:var(--action-teal);border-color:var(--action-teal);color:#fff;padding:14px 18px;font-size:15px}\n.flow.in .node{opacity:1;animation:rise 450ms var(--ease-out) backwards;animation-delay:calc(var(--i)*220ms)}\n@media (hover:hover){.flow.in .node:hover{transform:translateY(-3px) scale(1.03);border-color:var(--teal);box-shadow:0 10px 20px -12px rgba(74,3,7,.45)}}\n.link-v{display:flex;flex-direction:column;align-items:center;height:30px;position:relative;opacity:0;transition:opacity 400ms var(--ease-out);transition-delay:calc(var(--i)*220ms)}\n.flow.in .link-v{opacity:1}\n.link-v::before{content:\"\";flex:1;width:2px;background:var(--action-teal)}\n.link-v::after{content:\"\";width:0;height:0;border:6px solid transparent;border-top:8px solid var(--action-teal);border-bottom:0}\n.link-v.stop::after{border:0;width:22px;height:2px;background:var(--red)}\n.link-v.stop::before{background:var(--red)}\n.link-v.stop span{position:absolute;left:calc(50% + 14px);top:50%;transform:translateY(-50%);font:400 11.5px\/1 var(--font-body);color:var(--accent-text)}\n.pair{display:grid;grid-template-columns:1fr 1fr;gap:10px;max-width:340px;margin-inline:auto}\n.pair .node{max-width:none;font-size:13px;padding:10px 10px}\n.fork{max-width:340px;height:28px;margin-inline:auto;position:relative;opacity:0;transition:opacity 400ms var(--ease-out);transition-delay:calc(var(--i)*220ms)}\n.flow.in .fork{opacity:1}\n.fork::before{content:\"\";position:absolute;left:25%;right:25%;top:0;height:14px;border:2px solid var(--action-teal);border-bottom:0;border-radius:0}\n.fork::after{content:\"\";position:absolute;left:50%;top:-14px;height:14px;width:2px;background:var(--action-teal)}\n.fork i{position:absolute;top:14px;width:0;height:0;border:6px solid transparent;border-top:8px solid var(--action-teal);border-bottom:0}\n.fork i:first-child{left:calc(25% - 6px)}.fork i:last-child{right:calc(25% - 6px)}\n.pair-wrap{display:grid;gap:10px}\n.down-merge{margin-top:2px}\n\n\n\/* Gasflum additions *\/\n.pcard.wide{display:grid;grid-template-columns:auto 1fr;gap:clamp(20px,4vw,48px)}\n.pgrid{display:grid;grid-template-columns:repeat(3,1fr);gap:20px}\n.pgrid dt{font:500 11px\/1.2 var(--font-body);letter-spacing:.12em;text-transform:uppercase;color:var(--ink-muted)}\n.pgrid dd{font:600 16px\/1.35 var(--font-head);color:var(--teal-head);margin-top:6px}\n@media (max-width:760px){.pcard.wide{grid-template-columns:1fr;gap:16px}.pgrid{grid-template-columns:1fr}}\n.dn{color:var(--red);font-weight:600}\n.node.end.clock{display:flex;align-items:center;justify-content:center;gap:12px;max-width:260px;margin-top:14px;text-align:left;padding:12px 18px}\n.node.end.clock svg{flex:none;width:34px;height:34px;padding:7px;border-radius:50%;background:var(--red);stroke:#fff;fill:none;stroke-width:2;stroke-linecap:round;stroke-linejoin:round}\n.node.end.clock b{display:block;font:600 15px\/1.2 var(--font-head)}\n.node.end.clock small{color:#fff;opacity:.92;font-size:12px;margin-top:2px}\n.pair{margin-top:0}\n.steps p sup{font-size:.7em;line-height:0}\n\n\n\/* Media + FAQ additions *\/\n.split{display:grid;grid-template-columns:1.1fr .9fr;gap:clamp(28px,5vw,72px);align-items:center}\n.split.rev{grid-template-columns:.9fr 1.1fr}\n.media-wrap{position:relative;isolation:isolate}\n.media-wrap::before{content:\"\";position:absolute;right:-14px;bottom:-14px;width:62%;height:62%;border-radius:26px;background:linear-gradient(135deg,var(--teal-2),var(--green));opacity:.2;z-index:-1;transition:transform 500ms var(--ease-out),opacity 500ms var(--ease-out)}\n.split.rev .media-wrap::before{right:auto;left:-14px}\n.media{position:relative;border-radius:24px;overflow:hidden;aspect-ratio:4\/4;background:var(--surface)}\n.media img{width:100%;height:100%;object-fit:cover;display:block;transition:transform 900ms var(--ease-out)}\n@media (hover:hover){.media-wrap:hover .media img{transform:scale(1.05)}.media-wrap:hover::before{transform:translate(6px,6px);opacity:.32}.split.rev .media-wrap:hover::before{transform:translate(-6px,6px)}}\n@media (max-width:860px){.split,.split.rev{grid-template-columns:1fr}.split.rev .media-wrap{order:2}.media-wrap{max-width:560px}}\n.faq{background:var(--surface)}\n.faq-list{display:grid;gap:12px;max-width:880px}\n.faq-item{background:#fff;border:1px solid var(--line);border-radius:16px;overflow:hidden;transition:border-color 250ms var(--ease-out),box-shadow 250ms var(--ease-out),transform 250ms var(--ease-out)}\n@media (hover:hover){.faq-item:hover{transform:translateY(-2px);border-color:#e6b9bc;border-color:color-mix(in srgb,var(--teal-2) 40%,var(--line));box-shadow:0 16px 30px -22px rgba(74,3,7,.4)}}\n.faq-item.open{border-color:var(--teal-2);box-shadow:0 18px 34px -24px rgba(74,3,7,.45)}\n.faq-q{width:100%;display:flex;align-items:center;justify-content:space-between;gap:16px;min-height:48px;padding:20px 24px;background:none;border:0;cursor:pointer;text-align:left;font:600 17px\/1.4 var(--font-head);color:var(--teal-head)}\n.faq-q:focus-visible{outline-offset:-4px}\n.faq-ico{flex:none;width:34px;height:34px;border-radius:10px;background:var(--surface);display:grid;place-items:center;transition:background-color 250ms var(--ease-out),transform 350ms var(--ease-out)}\n.faq-ico svg{width:16px;height:16px;stroke:var(--teal);stroke-width:2.2;stroke-linecap:round;fill:none;transition:stroke 250ms var(--ease-out)}\n.faq-item.open .faq-ico{background:var(--teal);transform:rotate(45deg)}\n.faq-item.open .faq-ico svg{stroke:#fff}\n.faq-a{display:grid;grid-template-rows:0fr;transition:grid-template-rows 350ms var(--ease-out)}\n.faq-item.open .faq-a{grid-template-rows:1fr}\n.faq-a>div{overflow:hidden;visibility:hidden;transition:visibility 0s linear 350ms}\n.faq-item.open .faq-a>div{visibility:visible;transition-delay:0s}\n.faq-a p{padding:0 24px 22px;max-width:70ch;color:var(--ink-muted)}\n.faq-a p+p{padding-top:0;margin-top:-8px}\n\n\n\/* Note with background image *\/\n.note-box.has-bg{position:relative;overflow:hidden;isolation:isolate;border:0;color:#fff;min-height:260px;display:flex;flex-direction:column;justify-content:center;padding:clamp(32px,5vw,64px)}\n.note-box.has-bg .bg{position:absolute;inset:0;z-index:-2;overflow:hidden}\n.note-box.has-bg .bg img{width:100%;height:100%;object-fit:cover;object-position:0% 100%;display:block;transform:scale(1.02);transition:transform 1000ms var(--ease-out)}\n.note-box.has-bg::after{content:\"\";position:absolute;inset:0;z-index:-1;background:linear-gradient(100deg,rgba(var(--ov),.93) 0%,rgba(var(--ov),.86) 60%,rgba(var(--ov),.78) 100%)}\n.note-box.has-bg h3{color:#fff}\n.note-box.has-bg h3 .ico{background:rgba(255,255,255,.16);box-shadow:inset 0 0 0 1px rgba(255,255,255,.28)}\n.note-box.has-bg p{color:#fff;max-width:72ch;font-size:17.5px}\n.note-box.has-bg p::before{background:var(--green)}\n@media (hover:hover){.note-box.has-bg:hover .bg img{transform:scale(1.08)}}\n\/* Rounded-corner fix: clip every layer to the radius so hover scale never squares the corners *\/\n.note-box.has-bg{border-radius:20px;clip-path:inset(0 round 20px)}\n@media (hover:hover){.note-box.has-bg:hover{transform:translate3d(0,-4px,0);box-shadow:none}}\n.note-box.has-bg .bg,.note-box.has-bg .bg img,.note-box.has-bg::after{border-radius:20px}\n.note-box.has-bg .bg img{will-change:transform}\n\n\n\/* Note *\/\n.note{padding-block:0 clamp(40px,6vw,64px)}\n.note-box{background:var(--note);border:1px solid #f1dede;border-radius:20px;padding:26px clamp(20px,3vw,32px)}\n.note-box{transition:transform 300ms var(--ease-out),box-shadow 300ms var(--ease-out)}\n@media (hover:hover){.note-box:hover{transform:translateY(-4px);box-shadow:0 22px 38px -26px rgba(74,3,7,.5)}}\n.note-box h3{color:var(--teal-head);display:flex;align-items:center;gap:12px;font:600 19px\/1.2 var(--font-head);margin-bottom:12px}\n.note-box h3 .ico{width:38px;height:38px;border-radius:12px;background:var(--action-teal)}\n.note-box p{position:relative;padding-left:20px;color:var(--ink)}\n.note-box p::before{content:\"\";position:absolute;left:0;top:.7em;width:8px;height:8px;border-radius:50%;background:var(--teal-2)}\n\n\/* Quality *\/\n.quality{padding-top:96px}\n.qbox{border:1px solid var(--line);border-radius:20px;padding:clamp(22px,3vw,34px);box-shadow:0 14px 34px -24px rgba(14,42,51,.25)}\n.qbox h2{font:600 22px\/1.2 var(--font-head);margin-bottom:24px}\n.qgrid{display:grid;grid-template-columns:auto 1fr 1fr;gap:clamp(20px,3vw,40px);align-items:center}\n.gmp{width:112px;height:112px;object-fit:contain;flex:none;filter:drop-shadow(0 6px 12px rgba(74,3,7,.18));transition:transform 500ms var(--ease-out),filter 500ms var(--ease-out)}\n@media (hover:hover){.gmp:hover{transform:scale(1.08);filter:drop-shadow(0 10px 18px rgba(74,3,7,.24))}}\n.check{display:flex;gap:14px;color:var(--ink-muted);font-size:16px;line-height:1.55}\n.check{transition:transform 300ms var(--ease-out)}\n@media (hover:hover){.check:hover{transform:translateY(-4px)}.check:hover svg{transform:scale(1.18) rotate(-6deg)}}\n.check svg{transition:transform 300ms var(--ease-out);flex:none;width:26px;height:26px;stroke:var(--green);fill:none;stroke-width:1.8;stroke-linecap:round;stroke-linejoin:round;margin-top:2px}\n@media (max-width:900px){.qgrid{grid-template-columns:1fr;align-items:start}}\n\n\/* Reveal *\/\n.rv{opacity:0}\n.rv.in{opacity:1;animation:rise 600ms var(--ease-out) backwards;animation-delay:calc(var(--d,0)*80ms)}\n@keyframes rise{from{opacity:0;transform:translateY(18px)}to{opacity:1;transform:none}}\n.hero-art img{opacity:0;transition:opacity 700ms var(--ease-out),transform 900ms var(--ease-out)}\n.loaded .hero-art img{opacity:1;transform:none}\n@keyframes bob{0%,100%{translate:0 0}50%{translate:0 -8px}}\n.hero-art img{transform:translate(30px,24px) rotate(2deg)}\n.loaded .hero-art img{animation:bob 7s ease-in-out 1.2s infinite}\n.hero-copy>*{opacity:0;transform:translateY(14px);transition:opacity 600ms var(--ease-out),transform 600ms var(--ease-out)}\n.loaded .hero-copy>*{opacity:1;transform:none}\n.loaded .hero-copy>:nth-child(2){transition-delay:70ms}.loaded .hero-copy>:nth-child(3){transition-delay:140ms}.loaded .hero-copy>:nth-child(4){transition-delay:210ms}.loaded .hero-copy>:nth-child(5){transition-delay:280ms}\n\n@media (prefers-reduced-motion:reduce){\n  html{scroll-behavior:auto}\n  *,*::before,*::after{animation:none!important;transition-duration:.01ms!important;transition-delay:0ms!important}\n  .rv,.hero-copy>*,.hero-art img,.node,.link-v,.fork,.join{opacity:1!important;transform:none!important}\n  .steps{--line:1!important}\n}\n.no-js .rv,.no-js .hero-copy>*,.no-js .hero-art img,.no-js .node,.no-js .link-v,.no-js .fork,.no-js .join{opacity:1;transform:none}\n.no-js .steps{--line:1}\n\n\/* Q-Niflex additions *\/\n.pres4{grid-template-columns:repeat(4,1fr)!important}\n@media (max-width:1000px){.pres4{grid-template-columns:repeat(2,1fr)!important}}\n@media (max-width:560px){.pres4{grid-template-columns:1fr!important}}\n.pres4 .pcard{padding:24px}\n.pres4 .dose small{display:none}\n.pres4 .pcard{gap:14px}\n.pres4 .dose{font-size:clamp(34px,3.4vw,44px)}\n.pres4 .pgrid{display:block}\n.pres4 .pgrid dd{font-size:15px}\n.pcard .dose{color:#8a0109}\n.pcard .dose small{color:#e07f00}\n.cards .card.wide{grid-column:1\/-1}\n.cards .card.wide p{max-width:none}\n.card-h{display:flex;align-items:center;gap:14px;margin-bottom:10px}\n.card-h .ico{margin-bottom:0}\n.card-h h3{margin-bottom:0}\n.steps li{padding-bottom:28px}\n.pair.col2{margin-top:0}\n.pair.col2 .link-v{height:auto;min-height:30px;align-self:stretch}\n.pair.col2 .gap-l::after{display:none}\n.pair.col2 .gap-l{height:auto;align-self:stretch}\n.join{max-width:340px;height:16px;margin-inline:auto;position:relative;opacity:0;transition:opacity 400ms var(--ease-out);transition-delay:calc(var(--i)*220ms)}\n.flow.in .join{opacity:1}\n.join::before{content:\"\";position:absolute;left:25%;right:25%;bottom:0;height:16px;border:2px solid var(--action-teal);border-top:0}\n.join::after{content:\"\";position:absolute;left:50%;bottom:-14px;height:14px;width:2px;background:var(--action-teal)}\n.node.end small{color:#fff;opacity:.92}\n.pair .node small{font-size:11px}\n.chip.g{background:#f39200;color:#4a0307}\n.card ul{list-style:none;padding:0;display:grid;gap:10px}\n.card li{position:relative;padding-left:20px;color:var(--ink-muted);font-size:16.5px}\n.card li::before{content:\"\";position:absolute;left:0;top:.65em;width:8px;height:8px;border-radius:50%;background:var(--teal-2)}\n.cards.c3{grid-template-columns:repeat(3,1fr)}\n@media (max-width:900px){.cards.c3{grid-template-columns:1fr}}\n.lead{max-width:80ch;margin-bottom:28px;color:var(--ink)}\n.cards.c2{margin-bottom:20px}\n.note-box.has-bg ul{list-style:none;padding:0;display:grid;gap:12px;max-width:80ch}\n.note-box.has-bg li{position:relative;padding-left:20px;font-size:17.5px;line-height:1.6;color:#fff}\n.note-box.has-bg li::before{content:\"\";position:absolute;left:0;top:.7em;width:8px;height:8px;border-radius:50%;background:#f39200}\n.specs dd{overflow-wrap:break-word}\n\n.mech-text{border-left:4px solid #f39200;padding-left:24px;font:400 clamp(20px,2.4vw,24px)\/1.55 var(--font-body);color:var(--ink);max-width:34ch;align-self:center}\n.mech-grid.one{align-items:center}\n.node.soft{background:#f6e3e3;border-color:#ecd0d2}\n.node.dark{background:var(--teal-deep);border-color:var(--teal-deep);color:#fff}\n.node.dark small{color:#fff}\n.node .pill{display:block;width:max-content;margin:6px auto 0;background:#f39200;color:#fff;border-radius:999px;padding:5px 12px;font:600 12px\/1 var(--font-head)}\n.node.end.g{background:#f39200;border-color:#f39200;color:#4a0307}\n.card h4{font:600 16px\/1.3 var(--font-head);color:var(--ink);margin:14px 0 4px}\n.card h4:first-of-type{margin-top:4px}\n.card .sub p{font-size:16.5px}\n.note-box.has-bg .two{display:grid;grid-template-columns:1fr 1fr;gap:20px 40px;max-width:900px}\n@media (max-width:760px){.note-box.has-bg .two{grid-template-columns:1fr}}\n.note-box.has-bg .sub h4{font:600 17px\/1.3 var(--font-head);color:#f39200;margin-bottom:6px}\n.note-box.has-bg .sub p{padding-left:0;font-size:17px;max-width:none}\n.note-box.has-bg .sub p::before{display:none}\n.qbox .qgrid.one{grid-template-columns:auto 1fr}\n@media (max-width:900px){.qbox .qgrid.one{grid-template-columns:1fr}}\n\n.prose ul{list-style:none;padding:0;display:grid;gap:10px;margin-top:18px;max-width:68ch}\n.prose li{position:relative;padding-left:22px;color:var(--ink)}\n.prose li::before{content:\"\";position:absolute;left:0;top:.65em;width:9px;height:9px;border-radius:50%;background:linear-gradient(135deg,var(--teal-2),#f39200)}\n.prose .tagline{font:500 clamp(19px,2.2vw,22px)\/1.5 var(--font-head);color:var(--teal-head);border-left:4px solid #f39200;padding-left:20px;max-width:34ch}\n.sub-h{font:600 20px\/1.3 var(--font-head);color:var(--ink);margin:0 0 18px}\n.tbl-wrap{overflow-x:auto;border:1px solid var(--line);border-radius:16px;background:#fff}\n.tbl{width:100%;border-collapse:collapse;min-width:560px;font-size:16px}\n.tbl th{background:var(--teal-deep);color:#fff;text-align:left;font:600 14px\/1.3 var(--font-head);letter-spacing:.04em;padding:16px 20px}\n.tbl td{padding:15px 20px;border-top:1px solid var(--line);color:var(--ink-muted);vertical-align:top;transition:background-color 250ms var(--ease-out)}\n.tbl td:first-child{font:600 15.5px\/1.4 var(--font-head);color:var(--ink);width:26%}\n.tbl td.q{color:var(--teal-head);font-weight:500;background:#fbeded}\n.tbl th.q{background:var(--teal-2)}\n@media (hover:hover){.tbl tbody tr:hover td{background:#fbf3f3}.tbl tbody tr:hover td.q{background:#f6dcdc}}\n.stat2{display:grid;grid-template-columns:1fr 1fr;gap:20px;margin-bottom:28px}\n@media (max-width:640px){.stat2{grid-template-columns:1fr}}\n.stat{border:1px solid var(--line);border-radius:16px;padding:28px;background:#fff;transition:transform 300ms var(--ease-out),box-shadow 300ms var(--ease-out)}\n.stat .n{font:600 clamp(40px,5vw,60px)\/1 var(--font-head);color:#8a0109}\n.stat.q{background:linear-gradient(135deg,#4a0307,#a1020b);border-color:transparent}\n.stat.q .n{color:#fff}\n.stat.q p{color:#fff}\n.stat p{margin-top:10px;color:var(--ink-muted);font:500 15px\/1.4 var(--font-head)}\n.stat small{display:block;margin-top:6px;font-size:14px;color:var(--ink-muted)}\n.stat.q small{color:#fff;opacity:.9}\n@media (hover:hover){.stat:hover{transform:translateY(-4px);box-shadow:0 18px 30px -18px rgba(74,3,7,.45)}}\n.stg .dose{font-size:clamp(20px,2vw,24px)!important;line-height:1.2}\n.stg .pgrid>div+div{margin-top:14px}\n.stg .pgrid dt{margin-bottom:2px}\n.note-box.has-bg p::before{display:none}\n.note-box.has-bg .promise{font:600 clamp(28px,4vw,44px)\/1.15 var(--font-head);color:#f39200;margin-top:28px;padding-left:0}\n.note-box.has-bg .by{margin-top:10px;font:500 15px\/1.4 var(--font-head);letter-spacing:.04em;color:#fff;padding-left:0}\n.formula{width:100%;border-collapse:collapse;font-size:16px}\n.formula td{padding:12px 0;border-top:1px solid var(--line);vertical-align:top;color:var(--ink-muted)}\n.formula tr:first-child td{border-top:0}\n.formula td:first-child{font:600 15.5px\/1.4 var(--font-head);color:var(--ink);width:34%;padding-right:20px}\n.qpos{margin-top:14px;color:var(--ink-muted);font-size:16px}\n.chip.g{background:#f39200;color:#4a0307}\n.node.end.g{background:#f39200;border-color:#f39200;color:#4a0307}\n.node.end.g small{color:#4a0307}\n.hero-art img{max-height:460px;width:auto;max-width:100%;margin-inline:auto}\n.hero .chip{white-space:normal;max-width:100%}\n.hero-art{min-width:0}\n.hero .tag{line-height:1.5}\n.qpos{margin-top:22px}\n.qhead{display:flex;align-items:center;justify-content:space-between;gap:24px;margin-bottom:28px}\n.qhead h2{margin:0}\n.qhead .gmp{flex:none;width:96px;height:auto}\n.fgrid{display:grid;grid-template-columns:repeat(4,1fr);gap:16px}\n@media (max-width:1000px){.fgrid{grid-template-columns:repeat(2,1fr)}}\n@media (max-width:560px){.fgrid{grid-template-columns:1fr}.qhead{flex-direction:column-reverse;align-items:flex-start}}\n.fcat{background:#fbf3f3;border:1px solid var(--line);border-radius:14px;padding:20px;transition:transform 300ms var(--ease-out),box-shadow 300ms var(--ease-out),border-color 300ms}\n@media (hover:hover){.fcat:hover{transform:translateY(-4px);border-color:#a1020b;box-shadow:0 16px 28px -18px rgba(74,3,7,.5)}}\n.fcat h3{font:600 15.5px\/1.3 var(--font-head);color:#8a0109;margin:0 0 12px;padding-bottom:10px;border-bottom:2px solid #f39200}\n.fcat ul{list-style:none;padding:0;margin:0;display:flex;flex-wrap:wrap;gap:8px}\n.fcat li{background:#fff;border:1px solid var(--line);border-radius:999px;padding:6px 12px;font:500 14.5px\/1.3 var(--font-body);color:var(--ink)}\n.faq-q{white-space:normal;height:auto;text-transform:none;letter-spacing:normal}\n.faq-q>span:first-child{flex:1 1 auto;min-width:0;white-space:normal;overflow-wrap:break-word;word-break:normal}\n.faq-q .faq-ico{flex:none}\n.card .sub h4{margin-top:14px}\n.card .sub h4:first-child{margin-top:0}\n[type=\"button\"]:hover{background-color:transparent;color:var(--teal-head)}\n[type=\"button\"]:focus{background-color:transparent;color:var(--teal-head)}\n<\/style>\n<script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"FAQPage\", \"mainEntity\": [{\"@type\": \"Question\", \"name\": \"What is Q-Niflex?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Q-Niflex is a clinically engineered multi-pathway joint support formulation powered by QuanticSphere\u2122 PQNS, in the Joint Health & Musculoskeletal Support category. It delivers 16 synergistic actives in a single, gut-friendly formulation.\"}}, {\"@type\": \"Question\", \"name\": \"What is QuanticSphere\u2122 PQNS technology?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Q-Niflex applies QuanticSphere\u2122 Nano-Sphere Technology to deliver 16 synergistic actives with ~85\u201390% uptake, a dramatic improvement over the <20% absorption typical of standard formulations. It improves epithelial transport, protects actives from degradation, enhances solubility with controlled release, and provides gut-friendly delivery.\"}}, {\"@type\": \"Question\", \"name\": \"Which active ingredients does Q-Niflex contain?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Structural Support: Glucosamine, Chondroitin, Collagen Peptides, Hyaluronic Acid (HA). Anti-Inflammatory & Analgesia: Boswellia (AKBA), Curcumin, PEA, Rosehip, Arnebia, Cissus. Antioxidant & Cellular Defense: Moringa, Harad Polyphenols, Omega-3 EPA\/DHA. Bioavailability & Support: Piperine, Magnesium, Vitamin D.\"}}, {\"@type\": \"Question\", \"name\": \"Which pathways does Q-Niflex address?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Active ingredients are delivered systemically to joint tissues, targeting three simultaneous pathways: (1) structural support and cartilage regeneration, (2) anti-inflammatory modulation of 5-LOX, NF-\u03baB, COX-2, and leukotriene pathways, and (3) antioxidant protection neutralizing ROS and preserving compound stability.\"}}, {\"@type\": \"Question\", \"name\": \"How does Q-Niflex compare with standard joint supplements?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Absorption: 10\u201320% for standard supplements versus ~85\u201390% for Q-Niflex. Active ingredients: typically 1\u20134 versus 16 synergistic actives. Dose requirement: high versus lower. GI tolerability: variable versus gut-friendly. Mechanism coverage: single pathway versus multi-pathway.\"}}, {\"@type\": \"Question\", \"name\": \"What is the role of piperine in the formulation?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Piperine boosts curcumin absorption by inhibiting glucuronidation and enhancing intestinal permeability.\"}}, {\"@type\": \"Question\", \"name\": \"Who is Q-Niflex intended for?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Mild\u2013moderate OA patients seeking comprehensive joint support and symptom management; aging individuals facing age-related joint changes who want to maintain mobility, flexibility, and quality of life; active adults and athletes requiring joint protection, recovery support, and performance maintenance; and post-menopausal women as target population.\"}}, {\"@type\": \"Question\", \"name\": \"Does Q-Niflex replace medical advice?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"No. Supplements complement, not replace, medical advice. In Stage IV \u2014 Severe osteoarthritis, symptom control remains helpful and Q-Niflex provides adjunct relief; discuss comprehensive care with a clinician.\"}}]}<\/script>\n<\/head>\n<body class=\"no-js\">\n<a class=\"skip\" href=\"#main\">Skip to content<\/a>\n<span id=\"top\"><\/span>\n\n\n<main id=\"main\">\n<section class=\"hero\" aria-labelledby=\"h1\" style=\"padding:0\">\n  <canvas id=\"fx\" aria-hidden=\"true\"><\/canvas>\n  <div class=\"cx-wrap\">\n    <div class=\"hero-copy\">\n      <span class=\"tag\">Joint Health &amp; Musculoskeletal Support<\/span>\n      <h1 id=\"h1\">Q-Niflex<\/h1>\n      <p class=\"generic\">Clinically Engineered Multi-Pathway Joint Support<\/p>\n      <div class=\"strengths\" role=\"list\">\n        <span class=\"chip g\" role=\"listitem\">16 synergistic actives<\/span>\n        <span class=\"chip t\" role=\"listitem\">~85\u201390% uptake<\/span>\n        <span class=\"chip t\" role=\"listitem\">Powered by QuanticSphere\u2122 PQNS<\/span>\n      <\/div>\n      <div class=\"cta-row\">\n        <a class=\"btn btn-primary\" href=\"#mechanism\">Mechanism of Delivery &amp; Action<\/a>\n      <\/div>\n    <\/div>\n    <div class=\"hero-art\">\n      <img decoding=\"async\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/box-qniflex.png\" alt=\"Q-Niflex box\" width=\"500px\" height=\"1015\" title=\"\">\n    <\/div>\n  <\/div>\n<\/section>\n\n<div class=\"specs\">\n  <div class=\"cx-wrap\">\n    <ul>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9\"\/><circle cx=\"12\" cy=\"12\" r=\"3.500\"\/><path d=\"M12 3v5.500M12 15.500V21M3 12h5.500M15.500 12H21\"\/><\/svg><\/span><dl><dt>Technology<\/dt><dd>QuanticSphere\u2122 PQNS<\/dd><\/dl><\/li>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"m12 3 9 5-9 5-9-5 9-5Z\"\/><path d=\"m3 13 9 5 9-5\"\/><\/svg><\/span><dl><dt>Actives<\/dt><dd>16 synergistic actives<\/dd><\/dl><\/li>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3s6 6.500 6 11a6 6 0 0 1-12 0c0-4.500 6-11 6-11Z\"\/><\/svg><\/span><dl><dt>Uptake<\/dt><dd>~85\u201390%<\/dd><\/dl><\/li>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M7 4a2.500 2.500 0 0 0-2 4 2.500 2.500 0 0 0 3 3l6 6a2.500 2.500 0 0 0 3 3 2.500 2.500 0 0 0 4-2 2.500 2.500 0 0 0-3-3l-6-6a2.500 2.500 0 0 0-3-3A2.500 2.500 0 0 0 7 4Z\"\/><\/svg><\/span><dl><dt>Functional category<\/dt><dd>Joint Health &amp; Musculoskeletal Support<\/dd><\/dl><\/li>\n    <\/ul>\n  <\/div>\n<\/div>\n\n<section class=\"about\" aria-labelledby=\"what\">\n  <div class=\"cx-wrap split\">\n    <div class=\"prose rv\">\n    <h2 class=\"h2\" id=\"what\">What is Q-Niflex?<\/h2>\n    <p class=\"tagline\">Precision gut-friendly system for structural, anti-inflammatory, and antioxidant joint support \u2014 16 synergistic actives, ~85\u201390% uptake.<\/p>\n    <ul>\n      <li>16 synergistic actives encapsulated with QuanticSphere\u2122 nano-sphere technology for optimal delivery and protection.<\/li>\n      <li>~85\u201390% uptake \u2014 exceptional bioavailability compared to standard supplement formulations (&lt;20%).<\/li>\n      <li>Multi-pathway support: structural, anti-inflammatory, antioxidant mechanisms plus enhanced absorption.<\/li>\n    <\/ul>\n    <\/div>\n    <div class=\"media-wrap rv\" style=\"--d:1\"><div class=\"media\"><img loading=\"lazy\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/info-qniflex.jpg\" alt=\"\" width=\"1600\" height=\"1200\" loading=\"lazy\" decoding=\"async\" title=\"\"><\/div><\/div>\n  <\/div>\n<\/section>\n\n<section class=\"indications\" id=\"why\" aria-labelledby=\"why-h\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"why-h\">Why Joint Health Matters<\/h2>\n    <p class=\"lead rv\">Osteoarthritis is a complex, multi-factorial degenerative joint disease characterized by progressive cartilage breakdown, chronic inflammation, and oxidative stress. It represents one of the leading causes of disability in aging populations globally.<\/p>\n    <h3 class=\"sub-h rv\">Osteoarthritis Pathophysiology<\/h3>\n    <div class=\"cards c3\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M7 4a2.500 2.500 0 0 0-2 4 2.500 2.500 0 0 0 3 3l6 6a2.500 2.500 0 0 0 3 3 2.500 2.500 0 0 0 4-2 2.500 2.500 0 0 0-3-3l-6-6a2.500 2.500 0 0 0-3-3A2.500 2.500 0 0 0 7 4Z\"\/><\/svg><\/span><h3>Degenerative Cartilage Loss<\/h3><\/div>\n        <p>Progressive breakdown of articular cartilage leads to structural compromise and reduced joint function over time.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3c1 3.500 5 5.500 5 10a5 5 0 0 1-10 0c0-2 1-3 2-4 0 2 1 2.500 2 2.500C11 9 11 5.500 12 3Z\"\/><\/svg><\/span><h3>Inflammation &amp; Oxidative Stress<\/h3><\/div>\n        <p>Chronic inflammatory mediators and reactive oxygen species accelerate tissue damage and pain signaling pathways.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"14\" cy=\"4.500\" r=\"2\"\/><path d=\"m9 21 3-6-3-3 2-4 4 2 3 3M6 12l3-4\"\/><\/svg><\/span><h3>Reduced Mobility<\/h3><\/div>\n        <p>Joint stiffness, pain, and functional limitations significantly impact quality of life and daily activities.<\/p>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"fall\" id=\"gap\" aria-labelledby=\"gap-h\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"gap-h\">Why Conventional Formulations Fall Short<\/h2>\n    <p class=\"lead rv\">Current joint supplements and pharmacological interventions face critical limitations that compromise effectiveness and patient compliance.<\/p>\n    <div class=\"cards c3\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3s6 6.500 6 11a6 6 0 0 1-12 0c0-4.500 6-11 6-11Z\"\/><\/svg><\/span><h3>Low Absorption (&lt;20%)<\/h3><\/div>\n        <p>Poor bioavailability means most active ingredients never reach target tissues, wasting therapeutic potential.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M6 5h9a3.500 3.500 0 0 1 0 7H9a3.500 3.500 0 0 0 0 7h9\"\/><\/svg><\/span><h3>High Dose &amp; GI Issues<\/h3><\/div>\n        <p>Compensating with higher doses leads to gastrointestinal discomfort, poor tolerance, and reduced adherence.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M4 12h16M14 6l6 6-6 6\"\/><\/svg><\/span><h3>One-Dimensional Mechanisms<\/h3><\/div>\n        <p>Single-pathway approaches fail to address the complex, multi-factorial nature of osteoarthritis pathology.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:3\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3 2.500 20h19L12 3Z\"\/><path d=\"M12 10v4.500M12 17.200v.1\"\/><\/svg><\/span><h3>NSAIDs \u2014 Long-term risks<\/h3><\/div>\n        <p>Gastric, renal, and cardiovascular risks with prolonged use.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3 2.500 20h19L12 3Z\"\/><path d=\"M12 10v4.500M12 17.200v.1\"\/><\/svg><\/span><h3>Steroids<\/h3><\/div>\n        <p>Risk of joint damage and systemic effects with extended use.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M7 4a2.500 2.500 0 0 0-2 4 2.500 2.500 0 0 0 3 3l6 6a2.500 2.500 0 0 0 3 3 2.500 2.500 0 0 0 4-2 2.500 2.500 0 0 0-3-3l-6-6a2.500 2.500 0 0 0-3-3A2.500 2.500 0 0 0 7 4Z\"\/><\/svg><\/span><h3>Symptom-only relief<\/h3><\/div>\n        <p>No cartilage regeneration; no structural repair.<\/p>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"indications\" id=\"solution\" aria-labelledby=\"sol-h\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"sol-h\">The QuanticSphere\u2122 PQNS Solution<\/h2>\n    <p class=\"lead rv\">Q-Niflex applies QuanticSphere\u2122 Nano-Sphere Technology to deliver 16 synergistic actives with ~85\u201390% uptake \u2014 a dramatic improvement over the &lt;20% absorption typical of standard formulations.<\/p>\n    <h3 class=\"sub-h rv\">QuanticSphere\u2122 Platform Attributes<\/h3>\n    <div class=\"cards c2\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9\"\/><circle cx=\"12\" cy=\"12\" r=\"3.500\"\/><path d=\"M12 3v5.500M12 15.500V21M3 12h5.500M15.500 12H21\"\/><\/svg><\/span><h3>Improves Epithelial Transport<\/h3><\/div>\n        <p>Nano-sphere architecture facilitates efficient crossing of intestinal barriers.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3 4 6v6c0 4.500 3.500 7.500 8 9 4.500-1.500 8-4.500 8-9V6l-8-3Z\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><\/span><h3>Protects Actives from Degradation<\/h3><\/div>\n        <p>Encapsulation shields sensitive compounds from harsh gastric pH and enzymatic breakdown.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3s6 6.500 6 11a6 6 0 0 1-12 0c0-4.500 6-11 6-11Z\"\/><\/svg><\/span><h3>Enhances Solubility + Controlled Release<\/h3><\/div>\n        <p>Improves water solubility of lipophilic compounds while enabling sustained, controlled release kinetics.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:3\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M6 5h9a3.500 3.500 0 0 1 0 7H9a3.500 3.500 0 0 0 0 7h9\"\/><\/svg><\/span><h3>Gut-Friendly Delivery<\/h3><\/div>\n        <p>Gentle on the gastrointestinal system, reducing irritation and improving patient tolerance and long-term compliance.<\/p>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section id=\"mechanism\" aria-labelledby=\"moa\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"moa\">Mechanism of Delivery &amp; Action<\/h2>\n    <div class=\"mech-grid one\">\n      <p class=\"mech-text rv\">Active ingredients are delivered systemically to joint tissues, targeting three simultaneous pathways.<\/p>\n      <ol class=\"steps\" id=\"steps\" hidden><\/ol>\n\n      <div class=\"flow\" id=\"flow\" role=\"group\" aria-label=\"How Q-Niflex works\">\n        <p class=\"flow-title\">Mechanism of Delivery &amp; Action<\/p>\n        <span class=\"node primary\" style=\"--i:0\">Q-Niflex<small>16 actives \u00b7 QuanticSphere\u2122 PQNS<\/small><\/span>\n        <div class=\"link-v\" style=\"--i:1\"><\/div>\n        <span class=\"node\" style=\"--i:2\">01 \u00b7 Encapsulation<\/span>\n        <div class=\"link-v\" style=\"--i:3\"><\/div>\n        <span class=\"node\" style=\"--i:4\">02 \u00b7 Absorption &amp; Transport<\/span>\n        <div class=\"link-v\" style=\"--i:5\"><\/div>\n        <span class=\"node\" style=\"--i:6\">03 \u00b7 Multi-Pathway Cellular Delivery<\/span>\n        <div class=\"link-v\" style=\"--i:7\"><\/div>\n        <span class=\"node end g\" style=\"--i:8\">Structural \u00b7 Anti-Inflammatory \u00b7 Antioxidant<\/span>\n      <\/div>\n    <\/div>\n\n    <div class=\"cards c3\" style=\"margin-top:56px\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3 4 6v6c0 4.500 3.500 7.500 8 9 4.500-1.500 8-4.500 8-9V6l-8-3Z\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><\/span><h3>01 \u00b7 Encapsulation<\/h3><\/div>\n        <p>All 16 active ingredients are encapsulated within QuanticSphere\u2122 nanospheres, protecting sensitive compounds from gastric acid, enzymatic degradation, and early metabolic clearance.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9\"\/><circle cx=\"12\" cy=\"12\" r=\"3.500\"\/><path d=\"M12 3v5.500M12 15.500V21M3 12h5.500M15.500 12H21\"\/><\/svg><\/span><h3>02 \u00b7 Absorption &amp; Transport<\/h3><\/div>\n        <p>Nano-sphere architecture facilitates efficient crossing of intestinal epithelial barriers. Piperine additionally inhibits glucuronidation and enhances intestinal permeability, further boosting bioavailability of key actives including curcumin.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"m12 3 9 5-9 5-9-5 9-5Z\"\/><path d=\"m3 13 9 5 9-5\"\/><\/svg><\/span><h3>03 \u00b7 Multi-Pathway Cellular Delivery<\/h3><\/div>\n        <p>Active ingredients are delivered systemically to joint tissues, targeting three simultaneous pathways: (1) structural support and cartilage regeneration, (2) anti-inflammatory modulation of 5-LOX, NF-\u03baB, COX-2, and leukotriene pathways, and (3) antioxidant protection neutralizing ROS and preserving compound stability.<\/p>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"indications\" id=\"architecture\" aria-labelledby=\"arch-h\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"arch-h\">Active Ingredient Architecture<\/h2>\n    <div class=\"cards c3\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M7 4a2.500 2.500 0 0 0-2 4 2.500 2.500 0 0 0 3 3l6 6a2.500 2.500 0 0 0 3 3 2.500 2.500 0 0 0 4-2 2.500 2.500 0 0 0-3-3l-6-6a2.500 2.500 0 0 0-3-3A2.500 2.500 0 0 0 7 4Z\"\/><\/svg><\/span><h3>Structural Support Cluster<\/h3><\/div>\n        <div class=\"sub\"><h4>Glucosamine + Chondroitin<\/h4><p>Maintain cartilage matrix by providing essential building blocks for proteoglycan synthesis and structural integrity.<\/p><h4>Collagen Peptides<\/h4><p>Aid regeneration by stimulating chondrocyte activity and supporting extracellular matrix repair.<\/p><h4>Hyaluronic Acid<\/h4><p>Lubricates joints by maintaining synovial fluid viscosity and promoting smooth, pain-free articulation.<\/p><\/div>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3c1 3.500 5 5.500 5 10a5 5 0 0 1-10 0c0-2 1-3 2-4 0 2 1 2.500 2 2.500C11 9 11 5.500 12 3Z\"\/><\/svg><\/span><h3>Anti-Inflammatory Action Cluster<\/h3><\/div>\n        <div class=\"sub\"><h4>Boswellia (AKBA)<\/h4><p>5-LOX modulation reduces leukotriene synthesis, targeting key inflammatory pathways in joint tissues.<\/p><h4>Curcumin<\/h4><p>NF-\u03baB &amp; COX-2 balance through multi-target anti-inflammatory mechanisms at the cellular transcription level.<\/p><h4>PEA<\/h4><p>Adjunct mobility &amp; pain modulation through endocannabinoid system support and nociceptive pathway regulation.<\/p><h4>Rosehip<\/h4><p>Galactolipid content supporting inflammatory mediator balance.<\/p><h4>Arnebia<\/h4><p>Traditional botanical compounds with modern validated anti-inflammatory mechanisms.<\/p><h4>Cissus<\/h4><p>Supports joint comfort and functional movement capacity.<\/p><\/div>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"4\"\/><path d=\"M12 2v2.500M12 19.500V22M2 12h2.500M19.500 12H22M5 5l1.800 1.800M17.200 17.200 19 19M5 19l1.800-1.800M17.200 6.800 19 5\"\/><\/svg><\/span><h3>Antioxidant Defense &amp; Uptake Enhancement Cluster<\/h3><\/div>\n        <div class=\"sub\"><h4>Moringa &amp; Harad Polyphenols<\/h4><p>Protect actives through powerful antioxidant capacity, neutralizing free radicals and preserving compound stability.<\/p><h4>Omega-3 EPA\/DHA<\/h4><p>Cellular support via membrane integration, anti-inflammatory eicosanoid production, and neuroprotective effects.<\/p><h4>Piperine<\/h4><p>Boosts curcumin absorption by inhibiting glucuronidation and enhancing intestinal permeability.<\/p><h4>Magnesium<\/h4><p>Cofactor supporting enzymatic activity and neuromuscular function.<\/p><h4>Vitamin D<\/h4><p>Supports calcium metabolism and modulates inflammatory response.<\/p><\/div>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section id=\"evidence\" aria-labelledby=\"bio-h\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"bio-h\">Bioavailability &amp; Comparative Evidence<\/h2>\n    <div class=\"stat2\">\n      <div class=\"stat rv\"><div class=\"n\">10\u201320%<\/div><p>Absorption \u2014 Standard Supplements<\/p><\/div>\n      <div class=\"stat q rv\" style=\"--d:1\"><div class=\"n\">~85\u201390%<\/div><p>Absorption \u2014 Q-Niflex + QuanticSphere\u2122<\/p><\/div>\n    <\/div>\n    <p class=\"lead rv\">The dramatic improvement in bioavailability translates directly to enhanced therapeutic efficacy, reduced dosing requirements, and superior patient compliance.<\/p>\n    <h3 class=\"sub-h rv\">Comparative Advantages<\/h3>\n    <div class=\"tbl-wrap rv\"><table class=\"tbl\"><thead><tr><th scope=\"col\">Attribute<\/th><th scope=\"col\">Standard Joint Supplements<\/th><th class=\"q\" scope=\"col\">Q-Niflex (QuanticSphere\u2122)<\/th><\/tr><\/thead><tbody><tr><td>Absorption<\/td><td>10\u201320%<\/td><td class=\"q\">~85\u201390%<\/td><\/tr><tr><td>Active Ingredients<\/td><td>Typically 1\u20134<\/td><td class=\"q\">16 synergistic actives<\/td><\/tr><tr><td>Mechanism Coverage<\/td><td>Single pathway<\/td><td class=\"q\">Multi-pathway (structural + anti-inflammatory + antioxidant)<\/td><\/tr><tr><td>GI Tolerability<\/td><td>Variable<\/td><td class=\"q\">Gut-friendly<\/td><\/tr><tr><td>Dose Requirement<\/td><td>High<\/td><td class=\"q\">Lower<\/td><\/tr><tr><td>Cartilage Regeneration<\/td><td>Limited<\/td><td class=\"q\">Structural cluster included<\/td><\/tr><tr><td>Anti-inflammatory<\/td><td>Single-agent<\/td><td class=\"q\">5-LOX + NF-\u03baB + COX-2 + more<\/td><\/tr><tr><td>Antioxidant Defense<\/td><td>Absent or limited<\/td><td class=\"q\">Full ROS neutralization cluster<\/td><\/tr><\/tbody><\/table><\/div>\n  <\/div>\n<\/section>\n\n<section class=\"indications\" id=\"benefits\" aria-labelledby=\"ben-h\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"ben-h\">Clinical &amp; Functional Benefits<\/h2>\n    <h3 class=\"sub-h rv\">Mechanism to Ingredient Mapping<\/h3>\n    <div class=\"tbl-wrap rv\"><table class=\"tbl\"><thead><tr><th scope=\"col\">Pathological Mechanism<\/th><th scope=\"col\">Active Ingredients Addressing It<\/th><\/tr><\/thead><tbody><tr><td>Cartilage Wear<\/td><td>Glucosamine + Chondroitin + Collagen + HA \u2014 structural matrix support and regenerative capacity.<\/td><\/tr><tr><td>Inflammatory Mediators<\/td><td>Boswellia + Curcumin + Rosehip + Arnebia + Cissus \u2014 modulate multiple inflammatory pathways simultaneously.<\/td><\/tr><tr><td>Nociception &amp; Stiffness<\/td><td>PEA \u2014 targets pain perception and joint mobility through endocannabinoid system modulation.<\/td><\/tr><tr><td>Oxidative Stress<\/td><td>Curcumin + Rosehip + Arnebia + Moringa + Harad \u2014 neutralize ROS and protect tissues.<\/td><\/tr><tr><td>Bioavailability<\/td><td>Piperine &amp; QuanticSphere\u2122 technology \u2014 ensure maximum absorption and therapeutic delivery.<\/td><\/tr><\/tbody><\/table><\/div>\n    <h3 class=\"sub-h rv\" style=\"margin-top:56px\">Expected Outcomes by OA Stage<\/h3>\n    <div class=\"cards c2\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"m12 3 9 5-9 5-9-5 9-5Z\"\/><path d=\"m3 13 9 5 9-5\"\/><\/svg><\/span><h3>Stage I \u2014 Early<\/h3><\/div>\n        <div class=\"sub\"><h4>Description<\/h4><p>Great window for structure support + inflammation control.<\/p><h4>Expected Q-Niflex Contribution<\/h4><p>Structural reinforcement; preventive anti-inflammatory action.<\/p><\/div>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"m12 3 9 5-9 5-9-5 9-5Z\"\/><path d=\"m3 13 9 5 9-5\"\/><\/svg><\/span><h3>Stage II \u2014 Mild<\/h3><\/div>\n        <div class=\"sub\"><h4>Description<\/h4><p>Structure support + inflammation control.<\/p><h4>Expected Q-Niflex Contribution<\/h4><p>Multi-pathway relief begins; cartilage matrix support.<\/p><\/div>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"m12 3 9 5-9 5-9-5 9-5Z\"\/><path d=\"m3 13 9 5 9-5\"\/><\/svg><\/span><h3>Stage III \u2014 Moderate<\/h3><\/div>\n        <div class=\"sub\"><h4>Description<\/h4><p>Multi-pathway relief: 5-LOX + NF-\u03baB modulation, HA lubrication, collagen tolerance.<\/p><h4>Expected Q-Niflex Contribution<\/h4><p>Comprehensive symptom control and joint protection.<\/p><\/div>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:3\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"m12 3 9 5-9 5-9-5 9-5Z\"\/><path d=\"m3 13 9 5 9-5\"\/><\/svg><\/span><h3>Stage IV \u2014 Severe<\/h3><\/div>\n        <div class=\"sub\"><h4>Description<\/h4><p>Symptom control remains helpful; discuss comprehensive care with a clinician.<\/p><h4>Expected Q-Niflex Contribution<\/h4><p>Adjunct relief; supplements complement, not replace, medical advice.<\/p><\/div>\n      <\/article>\n    <\/div>\n    <h3 class=\"sub-h rv\" style=\"margin-top:56px\">Ideal Users \/ Target Population<\/h3>\n    <div class=\"cards c2\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"8\" r=\"4\"\/><path d=\"M4 21c0-4.500 3.500-7 8-7s8 2.500 8 7\"\/><\/svg><\/span><h3>Mild\u2013Moderate OA Patients<\/h3><\/div>\n        <p>Seeking comprehensive joint support and symptom management.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"14\" cy=\"4.500\" r=\"2\"\/><path d=\"m9 21 3-6-3-3 2-4 4 2 3 3M6 12l3-4\"\/><\/svg><\/span><h3>Aging Individuals<\/h3><\/div>\n        <p>Facing age-related joint changes who want to maintain mobility, flexibility, and quality of life.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M13 2 4 14h7l-1 8 9-12h-7l1-8Z\"\/><\/svg><\/span><h3>Active Adults and Athletes<\/h3><\/div>\n        <p>Requiring joint protection, recovery support, and performance maintenance.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:3\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"8\" r=\"4\"\/><path d=\"M4 21c0-4.500 3.500-7 8-7s8 2.500 8 7\"\/><\/svg><\/span><h3>Post-Menopausal Women<\/h3><\/div>\n        <p>Post-menopausal women as target population.<\/p>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"note\" aria-labelledby=\"imp\">\n  <div class=\"cx-wrap\">\n    <div class=\"note-box has-bg rv\" style=\"--ov:74,3,7\">\n      <div class=\"bg\" aria-hidden=\"true\"><img loading=\"lazy\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/info-qniflex.jpg\" alt=\"\" width=\"1600\" height=\"1200\" loading=\"lazy\" decoding=\"async\" title=\"\"><\/div>\n      <h3 id=\"imp\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M7 4a2.500 2.500 0 0 0-2 4 2.500 2.500 0 0 0 3 3l6 6a2.500 2.500 0 0 0 3 3 2.500 2.500 0 0 0 4-2 2.500 2.500 0 0 0-3-3l-6-6a2.500 2.500 0 0 0-3-3A2.500 2.500 0 0 0 7 4Z\"\/><\/svg><\/span>Conclusion &amp; Brand Promise<\/h3>\n      <p>Q-Niflex, powered by QuanticSphere\u2122, represents a paradigm shift in joint health supplementation \u2014 moving beyond single-ingredient approaches to deliver a clinically engineered, multi-pathway solution with ~85\u201390% uptake. Its 16 synergistic actives address every dimension of osteoarthritis pathology: structural repair, inflammation modulation, oxidative stress, and pain regulation \u2014 in a single, gut-friendly formulation.<\/p>\n      <p class=\"promise\">\u201cRebuilding Support. Reviving Mobility.\u201d<\/p>\n      <p class=\"by\">Q-Niflex powered by QuanticSphere\u2122<\/p>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"faq\" id=\"faq\" aria-labelledby=\"faq-h\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"faq-h\">Frequently Asked Questions<\/h2>\n    <div class=\"faq-list\">\n      <div class=\"faq-item rv\" style=\"--d:0\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q1\" aria-expanded=\"false\" aria-controls=\"faq-a1\"><span>What is Q-Niflex?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a1\" role=\"region\" aria-labelledby=\"faq-q1\"><div><p>Q-Niflex is a clinically engineered multi-pathway joint support formulation powered by QuanticSphere\u2122 PQNS, in the Joint Health &amp; Musculoskeletal Support category. It delivers 16 synergistic actives in a single, gut-friendly formulation.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:1\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q2\" aria-expanded=\"false\" aria-controls=\"faq-a2\"><span>What is QuanticSphere\u2122 PQNS technology?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a2\" role=\"region\" aria-labelledby=\"faq-q2\"><div><p>Q-Niflex applies QuanticSphere\u2122 Nano-Sphere Technology to deliver 16 synergistic actives with ~85\u201390% uptake, a dramatic improvement over the &lt;20% absorption typical of standard formulations. It improves epithelial transport, protects actives from degradation, enhances solubility with controlled release, and provides gut-friendly delivery.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:2\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q3\" aria-expanded=\"false\" aria-controls=\"faq-a3\"><span>Which active ingredients does Q-Niflex contain?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a3\" role=\"region\" aria-labelledby=\"faq-q3\"><div><p>Structural Support: Glucosamine, Chondroitin, Collagen Peptides, Hyaluronic Acid (HA). Anti-Inflammatory &amp; Analgesia: Boswellia (AKBA), Curcumin, PEA, Rosehip, Arnebia, Cissus. Antioxidant &amp; Cellular Defense: Moringa, Harad Polyphenols, Omega-3 EPA\/DHA. Bioavailability &amp; Support: Piperine, Magnesium, Vitamin D.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:3\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q4\" aria-expanded=\"false\" aria-controls=\"faq-a4\"><span>Which pathways does Q-Niflex address?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a4\" role=\"region\" aria-labelledby=\"faq-q4\"><div><p>Active ingredients are delivered systemically to joint tissues, targeting three simultaneous pathways: (1) structural support and cartilage regeneration, (2) anti-inflammatory modulation of 5-LOX, NF-\u03baB, COX-2, and leukotriene pathways, and (3) antioxidant protection neutralizing ROS and preserving compound stability.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q5\" aria-expanded=\"false\" aria-controls=\"faq-a5\"><span>How does Q-Niflex compare with standard joint supplements?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a5\" role=\"region\" aria-labelledby=\"faq-q5\"><div><p>Absorption: 10\u201320% for standard supplements versus ~85\u201390% for Q-Niflex. Active ingredients: typically 1\u20134 versus 16 synergistic actives. Dose requirement: high versus lower. GI tolerability: variable versus gut-friendly. Mechanism coverage: single pathway versus multi-pathway.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q6\" aria-expanded=\"false\" aria-controls=\"faq-a6\"><span>What is the role of piperine in the formulation?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a6\" role=\"region\" aria-labelledby=\"faq-q6\"><div><p>Piperine boosts curcumin absorption by inhibiting glucuronidation and enhancing intestinal permeability.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q7\" aria-expanded=\"false\" aria-controls=\"faq-a7\"><span>Who is Q-Niflex intended for?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a7\" role=\"region\" aria-labelledby=\"faq-q7\"><div><p>Mild\u2013moderate OA patients seeking comprehensive joint support and symptom management; aging individuals facing age-related joint changes who want to maintain mobility, flexibility, and quality of life; active adults and athletes requiring joint protection, recovery support, and performance maintenance; and post-menopausal women as target population.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q8\" aria-expanded=\"false\" aria-controls=\"faq-a8\"><span>Does Q-Niflex replace medical advice?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a8\" role=\"region\" aria-labelledby=\"faq-q8\"><div><p>No. Supplements complement, not replace, medical advice. In Stage IV \u2014 Severe osteoarthritis, symptom control remains helpful and Q-Niflex provides adjunct relief; discuss comprehensive care with a clinician.<\/p><\/div><\/div>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"quality\" id=\"quality\" aria-labelledby=\"qs\">\n  <div class=\"cx-wrap\">\n    <div class=\"qbox rv\">\n      <div class=\"qhead\">\n        <h2 id=\"qs\">Complete Clinical-Grade Formula Reference<\/h2>\n        <img decoding=\"async\" class=\"gmp\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/logo-gmp.png\" alt=\"GMP Certified Quality\" width=\"112\" height=\"112\" title=\"\">\n      <\/div>\n      <div class=\"fgrid\"><div class=\"fcat\"><h3>Structural Support<\/h3><ul><li>Glucosamine<\/li><li>Chondroitin<\/li><li>Collagen Peptides<\/li><li>Hyaluronic Acid (HA)<\/li><\/ul><\/div><div class=\"fcat\"><h3>Anti-Inflammatory &amp; Analgesia<\/h3><ul><li>Boswellia (AKBA)<\/li><li>Curcumin<\/li><li>PEA<\/li><li>Rosehip<\/li><li>Arnebia<\/li><li>Cissus<\/li><\/ul><\/div><div class=\"fcat\"><h3>Antioxidant &amp; Cellular Defense<\/h3><ul><li>Moringa<\/li><li>Harad Polyphenols<\/li><li>Omega-3 EPA\/DHA<\/li><\/ul><\/div><div class=\"fcat\"><h3>Bioavailability &amp; Support<\/h3><ul><li>Piperine<\/li><li>Magnesium<\/li><li>Vitamin D<\/li><\/ul><\/div><\/div>\n      <p class=\"qpos\"><strong>Positioning:<\/strong> Multi-pathway relief + structural support for comprehensive joint health management.<\/p>\n    <\/div>\n  <\/div>\n<\/section>\n<\/main>\n\n\n<script>\n(function(){\n  var d=document.documentElement,b=document.body;\n  b.classList.remove('no-js');\n  requestAnimationFrame(function(){requestAnimationFrame(function(){b.classList.add('loaded')})});\n\n  var io=new IntersectionObserver(function(es){es.forEach(function(e){\n    if(e.isIntersecting){e.target.classList.add('in');io.unobserve(e.target)}})},{threshold:.15,rootMargin:'0px 0px -6% 0px'});\n  document.querySelectorAll('.rv').forEach(function(el){io.observe(el)});\n\n\n  (function(){\n    var c=document.getElementById('fx');if(!c||!c.getContext)return;\n    var ctx=c.getContext('2d'),hero=c.parentElement,W=0,H=0,dpr=1,P=[],run=false,raf=0,mx=-999,my=-999;\n    var reduce=matchMedia('(prefers-reduced-motion: reduce)').matches;\n    function size(){var r=hero.getBoundingClientRect();dpr=Math.min(devicePixelRatio||1,2);W=r.width;H=r.height;c.width=W*dpr;c.height=H*dpr;ctx.setTransform(dpr,0,0,dpr,0,0);\n      var n=Math.round(Math.min(90,Math.max(28,W*H\/16000)));P=[];\n      for(var i=0;i<n;i++)P.push({x:Math.random()*W,y:Math.random()*H,vx:(Math.random()-.5)*.28,vy:(Math.random()-.5)*.28,r:Math.random()*1.4+.8});}\n    function draw(){\n      ctx.clearRect(0,0,W,H);var L=Math.min(150,W\/7);\n      for(var i=0;i<P.length;i++){var a=P[i];\n        if(!reduce){a.x+=a.vx;a.y+=a.vy;if(a.x<0||a.x>W)a.vx*=-1;if(a.y<0||a.y>H)a.vy*=-1;\n          var dx=a.x-mx,dy=a.y-my,d=dx*dx+dy*dy;if(d<14400){var f=(1-Math.sqrt(d)\/120)*.6;a.x+=dx*f*.02;a.y+=dy*f*.02}}\n        for(var j=i+1;j<P.length;j++){var b=P[j],ex=a.x-b.x,ey=a.y-b.y,e=ex*ex+ey*ey;\n          if(e<L*L){ctx.strokeStyle='rgba(224,196,236,'+(.22*(1-Math.sqrt(e)\/L))+')';ctx.lineWidth=1;ctx.beginPath();ctx.moveTo(a.x,a.y);ctx.lineTo(b.x,b.y);ctx.stroke()}}\n        ctx.fillStyle='rgba(240,222,247,.75)';ctx.beginPath();ctx.arc(a.x,a.y,a.r,0,6.2832);ctx.fill();}\n      if(run&&!reduce)raf=requestAnimationFrame(draw);}\n    function start(){if(!run){run=true;raf=requestAnimationFrame(draw)}}\n    function stop(){run=false;cancelAnimationFrame(raf)}\n    size();draw();\n    var rt;addEventListener('resize',function(){clearTimeout(rt);rt=setTimeout(function(){size();draw()},150)});\n    hero.addEventListener('pointermove',function(e){var r=hero.getBoundingClientRect();mx=e.clientX-r.left;my=e.clientY-r.top},{passive:true});\n    hero.addEventListener('pointerleave',function(){mx=my=-999});\n    new IntersectionObserver(function(es){es[0].isIntersecting?start():stop()}).observe(hero);\n  })();\n\n  document.querySelectorAll('.faq-q').forEach(function(b){\n    b.addEventListener('click',function(){\n      var it=b.closest('.faq-item'),open=it.classList.toggle('open');\n      b.setAttribute('aria-expanded',open?'true':'false');\n    });\n  });\n  var flow=document.getElementById('flow');\n  var fio=new IntersectionObserver(function(es){es.forEach(function(e){if(e.isIntersecting){flow.classList.add('in');fio.disconnect()}})},{threshold:.25});\n  fio.observe(flow);\n\n  var steps=document.getElementById('steps');\n  function line(){var r=steps.getBoundingClientRect(),h=innerHeight;\n    var p=Math.min(1,Math.max(0,(h*.75-r.top)\/r.height));steps.style.setProperty('--line',p)}\n  addEventListener('scroll',line,{passive:true});line();\n\n})();\n<\/script>\n<\/body>\n<\/html>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Q-Niflex (QuanticSphere\u2122 PQNS) \u2013 Crassula Skip to content Joint Health &amp; Musculoskeletal Support Q-Niflex Clinically Engineered Multi-Pathway Joint Support 16 synergistic actives ~85\u201390% uptake Powered by QuanticSphere\u2122 PQNS Mechanism of Delivery &amp; Action Technology QuanticSphere\u2122 PQNS Actives 16 synergistic actives Uptake ~85\u201390% Functional category Joint Health &amp; Musculoskeletal Support What is Q-Niflex? Precision gut-friendly system [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-12167","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages\/12167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/comments?post=12167"}],"version-history":[{"count":22,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages\/12167\/revisions"}],"predecessor-version":[{"id":12194,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages\/12167\/revisions\/12194"}],"wp:attachment":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/media?parent=12167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}